Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases

Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases

(2016) Kristýna Němejcová et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Racial disparities in melanoma survival

(2016) Sean M. Dawes et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Malignant Melanoma

(2016) Sabrina N. Pavri et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

BPTF transduces MITF-driven prosurvival signals in melanoma cells

(2016) Altaf A. Dar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways

(2014) A. Slominski et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy

(2014) Dongsheng Zhang et al.   CANCER LETTERS

Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma

(2013) Roxana S. Dronca et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis

(2013) Rubeta N. Matin et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation

(2013) Lu Wang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Targeted therapy for melanoma: rational combinatorial approaches

(2013) L N Kwong et al.   ONCOGENE

A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms

(2012) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo

(2012) Y. Liu et al.   MOLECULAR CANCER THERAPEUTICS

Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma

(2012) Seok Gun Park et al.   NUCLEAR MEDICINE AND BIOLOGY

Tumor Cell Plasticity and Angiogenesis in Human Melanomas

(2012) Daniela Mihic-Probst et al.   PLoS One

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker

(2011) Kátia C. Carvalho et al.   Clinics

Is there a role for carbohydrate restriction in the treatment and prevention of cancer?

(2011) Rainer J Klement et al.   Nutrition & Metabolism

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

(2010) Rita G Ladstein et al.   BMC CANCER

Glucose metabolism in cancer cells

(2010) Alessandro Annibaldi et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report

(2010) Ossia M. Eichhoff et al.   MELANOMA RESEARCH

Glucose transporters in the 21st Century

(2009) Bernard Thorens et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

(2009) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Biological Factors, Tumor Growth Kinetics, and Survival After Metastasectomy for Pulmonary Melanoma

(2009) Jonathan H. Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions

(2008) Paola Parente et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis

(2008) R. Brooks Robey et al.   SEMINARS IN CANCER BIOLOGY